| Affiliation: | 1. Pharmacology & Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel;2. Department of Infection, Immunity and Inflammation, Institute for Lung Health, University of Leicester, Leicester, UK;3. Clinical and Experimental Sciences, Faculty of Medicine, University of Southampton, Southampton, UK;4. NIHR Respiratory Biomedical Research Unit, Southampton General Hospital, Southampton, UK;5. Portsmouth Hospitals NHS Trust, Portsmouth, UK;6. Department of Otolaryngology/Head and Neck Surgery, Hadassah Hebrew University Medical Center, Jerusalem, Israel;7. Pharmacology & Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, IsraelEqually contributed to this work. Francesca Levi‐Schaffer, PharmD, PhD, Pharmacology & Experimental Therapeutics Unit, Institute for Drug Research, School of Pharmacy, Faculty of Medicine, The Hebrew University of Jerusalem, POB 12065, Jerusalem 91120, Israel.;8. Tel.: 972 2 6757512;9. Fax: 972 2 6758144;10. E‐mail: |
